Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
about
Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropeniaAntifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsRecommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1)Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.Clinical Translation of Nanomedicine.Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia.Impact of an intravenous fluconazole restriction policy on patient outcomes.Practice guidelines for lipid-based amphotericin B in stem cell transplant recipients.Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents.Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropeniaPre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry.Hematological toxicities associated with amphotericin B formulations.Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin BThe 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents.Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.Nanopharmaceuticals (part 1): products on the market.Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?Pulmonary reactions during treatment with amphotericin B: review of published cases and guidelines for management.Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings.Recommendations for the treatment of fungal pneumonias.The lipid formulations of amphotericin B.Systemic antifungal therapy: new options, new challenges.Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.Antifungal therapy and outcomes in infants with invasive Candida infections.Experience with community-based amphotericin B infusion therapy.Liposomal amphotericin B: clinical experience and perspectives.Use of antifungal drugs in hematologyMucormycosis spondylodiscitis after lumbar disc puncture.Emerging echinocandins for treatment of invasive fungal infections.Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisAn update on the use of antifungal agents.Clinical pharmacology of antifungal agents in pediatric patients.Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.Current options in antifungal pharmacotherapy.Nephrotoxicity in the setting of invasive fungal diseases.Treatment of invasive candidiasis in the elderly: a review
P2860
Q24193811-8A1E7636-20BF-4EA4-A6B4-15E73EB456E7Q24239978-FFD3ADD0-40E9-43DF-B4C2-7768B6574EEDQ26824260-CCE6B7E0-FA16-4259-BFEE-AE46EB0B79ECQ30240770-A8F27A16-F8A2-499F-B72B-1D0AEC1B7CEFQ30355939-651B6EBE-E8C0-44EC-BE35-5D283D252074Q30596268-7B8A341F-2B71-4F9E-B114-68AC4B7230E1Q30887348-A2E7617C-E7F4-4222-8286-7B8809D0A7F3Q31989784-29EC70BA-5BB1-4F31-9E97-56944CB2C077Q32052950-158BCB78-024E-42B1-AD4B-3FF4E35A0720Q33253851-4CAAC33C-1070-4E06-8BBA-2D8F02025376Q33265510-3907C22C-6007-40FE-8BEF-D2A0AC43FB32Q33371455-E132BEB8-26B7-4491-9EFC-65E2C573ACA0Q33420040-479AA83E-03AE-4479-AA8B-8A427CE7ADD6Q33722067-1FA37D2E-B4D9-4B4E-93AE-66D09EAE32A7Q33726292-60235DA7-E44C-4437-950A-D94076D7322DQ33876645-06A0A1A9-DDAA-41F8-B5E7-08E0AAF0D954Q34073422-35F431BA-BA6B-4935-BF0E-55C3F034AD6EQ34228354-5BD95CF0-EDCB-4BD8-902B-842C94CE23BDQ34230175-52669BFE-A20D-447F-BDD4-1543CEFC2925Q34294886-1698282C-11B1-41FF-95A9-62BC84E2B2CEQ34294904-07B121EA-DDA1-4FDA-A6C2-D93BB63874F3Q34350416-2BE96015-2F87-47B5-8921-27B218D2E363Q34801921-3AC7BDFC-173D-4DB1-85F8-D3EA23813E46Q35183728-C9F9ECEC-E0F6-4AEC-A609-1E77D6471624Q35183734-8F2984CE-5CF3-480F-B4DD-BB35EFC0B760Q35585219-DB77EAB9-0E34-4223-BED5-E6E7A6A219A2Q35715408-89235C0A-A4E2-4DC5-B878-AF4CEFEAE6CCQ35897495-5E93B082-C4E7-4CF0-AD16-AAA6DFCA25BBQ36130619-F57EE776-74EB-4D6B-9CED-019F3E052C63Q36140647-035FC3AF-2DC9-4F29-A356-A785D9DAF466Q36364856-0DE26842-E019-4030-BAB1-AFE733A62331Q36372241-0B528ABC-D557-44DB-B99F-F67B0C5EE049Q36458402-41E13ADD-83EA-4B52-ACF7-9F3ABF6D2DADQ36463811-5F03B5D5-1487-4899-A6CE-7318ADB7FF69Q36724783-6331E5D6-442E-4F7C-94DA-EF8FC395B193Q36968140-C992A18A-7B01-44F8-AEE8-CFB697C86CABQ37043539-EECACBCF-6414-4702-9D4A-540F4E0B7119Q37151326-A78EEDAC-98F8-4A49-A1D2-35BBFF4882DAQ37159573-8D1D1519-D683-4D39-8FFF-B1113FEC3156Q37170218-F8406242-147D-48B2-812D-EE24C5DB9855
P2860
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Randomized, double-blind clini ...... ment of fever and neutropenia.
@en
Randomized, double-blind clini ...... ment of fever and neutropenia.
@nl
type
label
Randomized, double-blind clini ...... ment of fever and neutropenia.
@en
Randomized, double-blind clini ...... ment of fever and neutropenia.
@nl
prefLabel
Randomized, double-blind clini ...... ment of fever and neutropenia.
@en
Randomized, double-blind clini ...... ment of fever and neutropenia.
@nl
P2093
P356
P1476
Randomized, double-blind clini ...... ment of fever and neutropenia.
@en
P2093
C B Miller
E S Sandler
G A Noskin
J A van Burik
J R Wingard
P304
P356
10.1086/514672
P407
P577
1998-08-01T00:00:00Z